Trade BIAF anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
bioAffinity Technologies, Inc. (BIAF) is trading at US$15.27, up 19.48% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$216.05K. Over the past 52 weeks, BIAF has traded between US$4.56 and US$202.50. On Syfe you can trade BIAF with $0 commission and add it to your watchlist.
| Previous close | US$12.78 |
|---|---|
| Market cap | US$216.05K |
| 52-week range | US$4.56 – US$202.50 |
| Volume | 19.05M |
| Exchange | US |
Add to Watchlist
Set Price Alert
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Year: 2022
BioAffinity Technologies Closes $3.2 Million Public Offering
Jun 18, 5:25 PM · MT Newswires
bioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%
Jun 17, 1:54 PM · MT Newswires
bioAffinity Technologies, Inc. (BIAF) stock is trading at US$15.27, +19.48% from the previous close of US$12.78.
The market cap for bioAffinity Technologies, Inc. (BIAF) stock is approximately US$216.05K.
The 52-week high for bioAffinity Technologies, Inc. (BIAF) stock is US$202.50.
The 52-week low for bioAffinity Technologies, Inc. (BIAF) stock is US$4.56.
bioAffinity Technologies, Inc. (BIAF) does not currently pay a dividend.
Stay on top of BIAF
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
